Raffaella Bloise

Medicine & Life Sciences

1. Long QT Syndrome 100%
2. Brugada Syndrome 86%
3. Polymorphic catecholergic ventricular tachycardia 54%
4. Cardiac Arrhythmias 44%
5. Mutation 33%
6. Timothy syndrome 32%
7. Genetic Testing 30%
8. Long QT syndrome type 3 26%
9. Genes 25%
10. Mexiletine 24%
11. Sudden Death 22%
12. Ryanodine Receptor Calcium Release Channel 22%
13. SHORT syndrome 21%
14. Syncope 19%
15. L-Type Calcium Channels 18%
16. Genetic Therapy 16%
17. Heart Arrest 15%
18. Ventricular Tachycardia 14%
19. Sudden Cardiac Death 13%
20. Hydroxychloroquine 13%
21. Coronavirus 12%
22. Implantable Defibrillators 12%
23. Bidirectional tachycardia 12%
24. Phenotype 12%
25. Electric Stimulation 11%
26. Risk Management 10%
27. L-type calcium channel alpha(1C) 10%
28. Electrocardiography 10%
29. Genetic Association Studies 10%
30. Arrhythmogenic Right Ventricular Dysplasia 10%
31. Natural History 10%
32. hydroquinidine 9%
33. Sodium Channels 9%
34. Andersen Syndrome 8%
35. Channelopathies 8%
36. Bundle-Branch Block 8%
37. Inborn Genetic Diseases 8%
38. Epidemiology 7%
39. Therapeutics 7%
40. Flecainide 7%
41. Quinidine 6%
42. Nadolol 6%
43. Italy 6%
44. Genetic Heterogeneity 6%
45. Genetic Profile 6%
46. Calcium-Calmodulin-Dependent Protein Kinase Type 2 6%
47. Sympathectomy 6%
48. Sudden Infant Death 6%
49. Emergency Treatment 6%
50. Genotype 5%